LPS (Lipopolysaccharide) is an endotoxin which exists as a critical glycolipid component of the outer cell wall of gram-negative bacteria. This compound is a known, potent initiator of the proinflammatory response and induces proinflammatory cytokines in several cell types. Many of the cell signals induced by gram-negative bacteria are attributed to LPS and have been observed to also activate TNF receptor signaling pathways. The major receptor that transduces the LPS signal has been recognized as a member of the Toll-like receptor family. At least 10 members of the family have been identified to date and TLR4 appears to be the main LPS receptor although coreceptors are most likely involved. Studies note that in HMEC (human microvascular endothelial cells) cell lines, LPS activates apoptosis pathways via both NF-κB and JNK through TRAF6. Also reported that NF-κB inhibition does not potentiate LPS-induced death in HMEC cells yet will sensitize these cell to TNF-induced death. Additional studies using HMEC cell lines report that following LPS stimulation, TRAF6 also transmits an important endothelial cell survival signal in a situation of complete NF-κB blockade which may indicate that TRAF6 signals an NF-κB–independent antiapoptotic pathway in endothelial cells exposed to LPS.
1. Zhang, F.X., et al. 1999. J. Biol. Chem. 274: 7611-7614. PMID: 10075645
2. Hull, C., et al. 2002. J. Immunol. 169: 2611-2618. PMID: 12193732
3. Raschi, E., et al. 2003. Blood. 101: 3495-3500. PMID: 12531807
4. Pollet, I., et al. 2003. Blood. 102: 1740-1742. PMID: 12714497
5. Wong, F., et al. 2004. Blood. 103: 4520-4526. PMID: 14996708
6. Wang, J., et al. 2008. J. Immunol. 180: 8011-8019. PMID: 18523264
See how others have used LPS. Click on the entry to view the PubMed entry .
PMID: # 30914954 Rossaneis, AC.|Longhi-Balbinot, DT.|Bertozzi, MM.|Fattori, V.|Segato-Vendrameto, CZ.|Badaro-Garcia, S.|Zaninelli, TH.|Staurengo-Ferrari, L.|Borghi, SM.|Carvalho, TT.|Bussmann, AJC.|Gouveia, FS.|Lopes, LGF.|Casagrande, R.|Verri, WA.| et al. 2019. Front Pharmacol. 10: 229.
PMID: # 30938885 Yang, J.|Li, R.|Zhao, D.|Zheng, S.| et al. 2019. J. Cell. Biochem. 120: 12887-12903.
PMID: # 29058362 Huang, C. et al. 2018. Glia. 66: 256-278.
PMID: # 29581852 Wang, Q.|Yang, X.|Xu, Y.|Shen, Z.|Cheng, H.|Cheng, F.|Liu, X.|Wang, R.| et al. 2018. Oncotarget. 9: 14397-14412.
PMID: # 30247686 Miklavcic, JJ.|Badger, TM.|Bowlin, AK.|Matazel, KS.|Cleves, MA.|LeRoith, T.|Saraf, MK.|Chintapalli, SV.|Piccolo, BD.|Shankar, K.|Yeruva, L.| et al. 2018. J. Nutr. 148: 1860-1870.
PMID: # 28966794 Fiedler, SE.|George, JD.|Love, HN.|Kim, E.|Spain, R.|Bourdette, D.|Salinthone, S.| et al. 2017. J Syst Integr Neurosci. 3:
PMID: # 28515460 Giakoumelou, S.|Wheelhouse, N.|Brown, J.|Wade, J.|Simitsidellis, I.|Gibson, D.|Saunders, PTK.|Horner, P.|Entrican, G.|Howie, SEM.|Horne, AW.| et al. 2017. Sci Rep. 7: 2001.
PMID: # 28410266 Chen, Z. et al. 2017. Behav Pharmacol. 28: 365-374.
PMID: # 27753084 Ren, JP. et al. 2017. Immunology. 150: 213-220.
PMID: # 28508104 Ruiz-Miyazawa, KW.|Staurengo-Ferrari, L.|Mizokami, SS.|Domiciano, TP.|Vicentini, FTMC.|Camilios-Neto, D.|Pavanelli, WR.|Pinge-Filho, P.|Amaral, FA.|Teixeira, MM.|Casagrande, R.|Verri, WA.| et al. 2017. Inflammopharmacology.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.